EMB: A Protein Potential Drug Target (G133418)

Target Name: EMB

NCBI ID: G133418

Content of Review Report on EMB Target / Biomarker

EMB

EMB: A Protein Potential Drug Target

EMB (MGC71745) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the Eph receptor tyrosine kinase (EGT) family, which is a group of transmembrane proteins that play a crucial role in the development and maintenance of tissues and organs.

EMB is known for its role in the regulation of cell proliferation and differentiation. It has been shown to play a key role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of EMB is its potential as a drug target. Its ability to interact with various signaling pathways, including the TGF-β pathway, has led to its potential as a therapeutic agent for a variety of conditions.

EMB has been shown to play a role in the regulation of TGF-β signaling, which is a key pathway involved in the development and maintenance of tissues and organs. This is important because many diseases, including cancer, are caused by disruptions in TGF- 尾 signaling.

In addition to its role in TGF-β signaling, EMB has also been shown to play a role in the regulation of cell adhesion. This is important because the ability of cells to stick together is critical for the development and maintenance of tissues and organs.

EMB has also been shown to play a role in the regulation of cell migration. This is important because the ability of cells to move and migrate is critical for the development and maintenance of tissues and organs.

In conclusion, EMB is a protein that has the potential to be a drug target for a variety of conditions. Its ability to interact with various signaling pathways, including TGF-β and cell adhesion, makes it an attractive candidate for therapeutic intervention. Further research is needed to fully understand the role of EMB in the development and maintenance of tissues and organs, and to determine its potential as a therapeutic agent.

Protein Name: Embigin

Functions: Plays a role in the outgrowth of motoneurons and in the formation of neuromuscular junctions. Following muscle denervation, promotes nerve terminal sprouting and the formation of additional acetylcholine receptor clusters at synaptic sites without affecting terminal Schwann cell number or morphology. Delays the retraction of terminal sprouts following re-innervation of denervated endplates. May play a role in targeting the monocarboxylate transporters SLC16A1 and SLC16A7 to the cell membrane (By similarity)

The "EMB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EMB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets